Second Line Capital, LLC Bristol Myers Squibb CO Transaction History
Second Line Capital, LLC
- $371 Billion
- Q4 2024
A detailed history of Second Line Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Second Line Capital, LLC holds 3,539 shares of BMY stock, worth $192,627. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,539
Previous 5,483
35.46%
Holding current value
$192,627
Previous $284 Million
29.44%
% of portfolio
0.05%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,745Shares Held
1.57BCall Options Held
27.9MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.64 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.23 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.18 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.28 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $116B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...